Received Jun 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | W036624 | — |
No additional AE reported.; A HCP called and reported that an expired dose of RECOMBIVAX HB was administered to a patient on 6/23/2025 with expiry date of 5/23/2025. The caller confirmed the dose has never been stored outside of the recommended range. No symptoms reported. Call; Primary Product Identification: Primary Product Name: RECOMBIVAX HB INJ 10/1.0 mcrg/ml ------------------------- Product Details #1 (Primary Product) : Product Name: RECOMBIVAX HB INJ 10/1.0 mcrg/ml Lot Number: w036624 Expiration Date: 5/23/2025 Operator of Device: Health Professional Obtain: False Hazardous Product?: False ------------------------- Adverse Event Details: Description: A HCP called and reported that an expired dose of RECOMBIVAX HB was administered to a patient on 6/23/2025 with expiry date of 5/23/2025. The caller confirmed the dose has never been stored outside of the recommended range. No symptoms reported. Caller declined to report the AE at this time. Consent was obtained to follow up with the HCP. No additional AE reported. No PQC. AE Onset Date/Date PQC First Identified: 6/23/2025 ------------------------- PQC Details: PQC Present?: false QIR Requested?: False -------------------------